Terug
Dagbereik
€ 5,33
€ 5,50
52-Weeksbereik
€ 4,40
€ 9,77
Volume
3.818.125
50D / 200D Gem.
€ 5,49
/
€ 7,20
Vorige Slotkoers
€ 5,48
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (627 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -4,8 | 0,3 |
| P/B | 0,7 | 2,9 |
| ROE % | -13,9 | 3,7 |
| Net Margin % | -7,9 | 3,8 |
| Rev Growth 5Y % | 5,6 | 10,0 |
| D/E | 0,8 | 0,2 |
Koersdoel Analisten
Geen analistendekking beschikbaar
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2030 |
€ 0,14
€ 0,14 – € 0,14
|
2,9 B | 5 |
| FY2029 |
-€ 0,16
-€ 0,16 – -€ 0,15
|
2,7 B | 2 |
| FY2028 |
-€ 0,72
-€ 1,31 – € 0,36
|
2,6 B | 7 |
Belangrijkste Punten
Revenue grew 5,62% annually over 5 years — modest growth
Generating 285,46M in free cash flow
PEG of 0,08 suggests growth is underpriced
Revenue growth is decelerating — 1Y growth trails 5Y average by 7,16%
Capital efficient — spends only 0,35% of revenue on capex
Groei
Revenue Growth (5Y)
5,62%
Revenue (1Y)-1,54%
Earnings (1Y)N/A
FCF Growth (3Y)21,41%
Kwaliteit
Return on Equity
-13,93%
ROIC-8,13%
Net Margin-7,92%
Op. Margin-10,39%
Veiligheid
Debt / Equity
0,75
Current Ratio2,69
Interest Coverage-13,34
Waardering
P/E Ratio
-4,83
P/B Ratio0,70
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -1,54% | Revenue Growth (3Y) | -1,40% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 5,62% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 2,53B | Net Income (TTM) | -200,32M |
| ROE | -13,93% | ROA | -6,46% |
| Gross Margin | 69,50% | Operating Margin | -10,39% |
| Net Margin | -7,92% | Free Cash Flow (TTM) | 285,46M |
| ROIC | -8,13% | FCF Growth (3Y) | 21,41% |
| Safety | |||
| Debt / Equity | 0,75 | Current Ratio | 2,69 |
| Interest Coverage | -13,34 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -4,83 | P/B Ratio | 0,70 |
| P/S Ratio | 0,38 | PEG Ratio | 0,08 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 966,91M | Enterprise Value | 1,23B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 2,53B | 2,57B | 2,60B | 2,41B | 2,03B |
| Net Income | -200,32M | -1,00B | -220,37M | -13,66B | -428,79M |
| EPS (Diluted) | -1,14 | -5,87 | -1,34 | -84,60 | -2,73 |
| Gross Profit | 1,76B | 1,82B | 1,84B | 1,66B | 1,38B |
| Operating Income | -262,96M | -1,02B | -248,55M | -13,65B | -265,63M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 3,10B | 3,52B | 4,39B | 4,70B | 17,73B |
| Total Liabilities | 1,72B | 2,03B | 2,07B | 2,39B | 1,69B |
| Shareholders' Equity | 1,39B | 1,49B | 2,33B | 2,31B | 16,05B |
| Total Debt | 1,04B | 1,58B | 1,59B | 1,59B | 1,28B |
| Cash & Equivalents | 781,08M | 1,30B | 1,12B | 918,18M | 893,48M |
| Current Assets | 1,09B | 1,66B | 1,49B | 1,29B | 1,23B |
| Current Liabilities | 404,74M | 941,54M | 420,62M | 399,77M | 331,01M |